Most recent update: Wednesday, August 15, 2018 - 09:49

Bariatric News - Cookies & privacy policy

You are here

GERD treatment

Study assessing Medigus MUSE System for GERD

Medigus MUSE endoscope
The research trial will serve to collect more data on the use of the device and there is no expense to the enrolled patients for the procedure and participation is expected to last approximately three years post-surgery.

A clinical trial at UC San Diego Health is assessing the Medigus MUSE System that reconstructs the oesophagus through the mouth and requires no incisions to treat treats gastroesophageal reflux (GERD). The international clinical trial will include 200 participants, 20 from UC San Diego Health, who are at least 18-years-old. The research trial will serve to collect more data on the use of the device. There is no expense to the enrolled patients for the procedure and participation is expected to last approximately three years post-surgery.

Using an endoscopic approach, the Medigus MUSE System staples the upper part of the stomach to the lower oesophagus about 3cms above the area where the two connect. The procedure creates a barrier of sorts to prevent contents from the stomach from flowing back up the muscular feeding tube.

“Traditional treatments for chronic GERD include over-the-counter medications for symptom management, but this new device provides a long-term solution by restoring a patient’s oesophageal anatomy through a minimally invasive approach,” said Dr Santiago Horgan, principal investigator of the clinical trial and chief of minimally invasive surgery at UC San Diego Health. “Patients will experience a faster recovery time with a shorter hospital stay.”

Horgan said that due to an increasing obesity rate and diet and lifestyle changes, GERD is on the rise. Extra weight places pressure on the stomach, which can prevent the lower oesophageal sphincter (LES) from opening and closing properly, failing to sufficiently contain stomach contents.

Medigus MUSE system

Patients describe the condition as painful with a constant burning sensation in the throat and chest cavity. GERD is often associated with the inability to sleep, dietary constraints and could lead to a precancerous condition called Barrett’s oesophagus.

“GERD can significantly impact a patient’s quality of life, so it’s critical that we continue to study new ways to permanently treat the condition using technological advancements in the field,” said Horgan, an international expert in treating oesophageal disease.

Co-Investigators for the trial at UC San Diego Health are Drs Garth Jacobsen, Bryan Sandler Sarah Lazar.

Patients interested in enrolling in the clinical trial at UC San Diego Health are asked to call 619-471-0447 or e-mail misresearch@ucsd.edu

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.